New anticancer drug delivery strategy releases payload without entering cells

Researchers have developed a binding-to-release drug conjugate strategy that delivers anticancer payloads to tumour cells without requiring cellular internalization. The approach improves tumour specificity and therapeutic efficacy compared with conventional drug conjugates. It also expands the range of viable therapeutic targets, potentially opening new avenues in oncology.